ACSS2 and metabolic diseases: from lipid metabolism to therapeutic target
Abstract Elevated incidence of metabolic disorders has been reported worldwide in the recent decade, highlighting the need for developing efficient therapies. These diseases result from a complex interplay of various factors that contribute to disease progression, complications, and resistance to cu...
Saved in:
| Main Authors: | Alaa El-Kurjieh, Reem Al-Arab, Qamar Abou Hachem, José-Noel Ibrahim, Philippe Hussein Kobeissy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | Lipids in Health and Disease |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12944-025-02491-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dual inhibition of hepatic ACLY and ACSS2: A synergistic approach to combat NAFLD through lipogenesis reduction and mitochondrial enhancement
by: Mengdi Zhang, et al.
Published: (2025-05-01) -
The coordinated regulatory impact of AcsS and TpdA on biofilm formation in Vibrio parahaemolyticus
by: Bin Ni, et al.
Published: (2025-08-01) -
Evaluating the mechanical and thermal performance of high-temperature low sag (HTLS) conductors: A comparative study of ACCC, ACSS, and ACSR conductors
by: Pooya Parvizi, et al.
Published: (2025-06-01) -
ACSS2‐Mediated Histone H4 Lysine 12 Crotonylation (H4K12cr) Alleviates Colitis via Enhancing Transcription of CLDN7
by: Ming Yuan, et al.
Published: (2025-08-01) -
Anti-obesity carbonic anhydrase inhibitors: challenges and opportunities
by: Claudiu T. Supuran
Published: (2022-12-01)